TABLE 3.
All patients (n = 83) |
Sarcopenia (n = 35) |
Non‐sarcopenia (n = 48) |
p Value | |
---|---|---|---|---|
GC genotype | ||||
Gc1f‐1f | 25 (30.1%) | 11 (31.4%) | 14 (29.2%) | 0.532 |
Gc1s‐1f | 22 (26.5%) | 12 (34.3%) | 10 (20.8%) | |
Gc1s‐1s | 4 (4.8%) | 1 (2.9%) | 3 (6.3%) | |
Gc2‐1f | 19 (22.9%) | 6 (17.1%) | 13 (27.1%) | |
Gc2‐1s | 10 (12.1%) | 3 (8.6%) | 7 (14.6%) | |
Gc2‐2 | 3 (3.6%) | 2 (5.7%) | 1 (2.1%) | |
GC allele | ||||
Gc1f | 91 (54.8%) | 40 (57.1%) | 51 (53.1%) | 0.785 |
Gc1s | 40 (24.1%) | 17 (24.3%) | 23 (24.0%) | |
Gc2 | 35 (21.1%) | 13 (18.6%) | 22 (22.9%) |
Data were presented as number (percentage).